article thumbnail

Neurocrine Biosciences’ Crenessity Approved as First New Treatment in Decades for Rare Genetic Disorder CAH

XTalks

CAH is a group of rare genetic disorders affecting the adrenal glands, which produce essential hormones like cortisol, aldosterone and androgens. The most common form of CAH, 21-hydroxylase deficiency, disrupts hormone production, leading to cortisol deficiency and an overproduction of androgens.

Genetics 116
article thumbnail

Valor Compounding Pharmacy™ is the Choice for Hormone Testing and Balancing

BioTech 365

Valor Compounding Pharmacy™ is the Choice for Hormone Testing and Balancing Valor Compounding Pharmacy™ is the Choice for Hormone Testing and Balancing Saliva testing kits, available to order online, allow patients to test their hormone levels from the comfort of … Continue reading →

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications.

BioTech 365

MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications. MEDISCA Pledges $100,000 to Alliance for Pharmacy Compounding (APC) National Media Campaign to Help Protect Compounded Hormone Therapy Medications. PLATTSBURGH, N.Y.–(BUSINESS

article thumbnail

Roche Invests $5.3B in Zealand’s Petrelintide, an Obesity Drug Candidate

XTalks

Amylin, a hormone co-secreted with insulin, plays a key role in regulating appetite by enhancing leptins effects the hormone that signals fullness after eating. Petrelintide, Zealand Pharmas long-acting amylin analog, is currently in Phase II clinical development and is designed for once-weekly subcutaneous injections.

article thumbnail

New Zepbound TV Commercial Inspires ‘Change’

XTalks

Related: Eli Lillys Zepbound Approved as First Treatment for Obstructive Sleep Apnea The commercial describes Zepbounds mechanism of action as a dual receptor against that works by activating two naturally occurring hormone receptors in [the] body [GLP-1 and GIP-1]. Late last year, Zepbound brought in $1.26

article thumbnail

Leading pharmaceutical compounding companies in contract marketing

Pharmaceutical Technology

Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. Discover the top pharmaceutical compounding companies in contract marketing.

Marketing 100
article thumbnail

LegitScript Finds 1200 Percent Increase in Problematic Ads for Compounded GLP-1 Meds

XTalks

Compounded GLP-1 medications, created by specialized pharmacies under a special US Food and Drug Administration (FDA) allowance due to ongoing shortage, have become increasingly popular for weight loss. The report also shows a rapid rise in compounding pharmacies.

Pharmacy 104